- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Sorafenib – November 2012
Sorafenib, tablet, 200 mg (as tosylate), Nexavar®
Last updated
8 November 2023